Compare Tenet Healthcare Corporation (THC) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Global X Uranium ETF — how do they compare? Tenet Healthcare Corporation trades at $268.26 (market cap $21.48B), while Global X Uranium ETF trades at $45.27. The key difference: Tenet Healthcare Corporation is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| THC | URA | |
|---|---|---|
Market Cap | $21.48B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $266.79 | $61.81 |
52-Week Low | $161.37 | $36.45 |
Enterprise Value | $32.56B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $266.79, up 2.64% today, with strong technical momentum indicated by a golden cross and bullish moving averages. The stock shows robust fundamentals with a P/E of 10.03, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights Zacks' Strong Buy rating and positive Q2 2026 results, with revenue growth and raised 2026 outlook driving investor optimism.
The outlook remains positive given analyst consensus of a $281.44 price target and 81% buy ratings, though risks include policy headwinds and net cash outflows. Earnings growth and ambulatory segment strength present opportunities, but investors should monitor expense management and regulatory changes that could impact margins.
URA, the Global X Uranium ETF, trades at $45.20, up 1.85% on the day, with a bullish technical signal from moving averages and strong buying pressure indicated by ADX. The ETF benefits from positive sentiment around nuclear energy demand driven by AI power needs and government support, including a recent $17.5 billion U.S. loan commitment for new reactors. However, RSI levels suggest potential overbought conditions near-term.
The outlook for URA is positive due to structural tailwinds in nuclear energy, but risks include ETF expense ratios and uranium price volatility. Investor sentiment is bolstered by index expansions and geopolitical deals, yet the fund lacks traditional valuation metrics as it holds diversified uranium-related equities rather than operating as a single company.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
